<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<style type="text/css">
.txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url("0.ttf"); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url("1.ttf"); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url("2.ttf"); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
.f4 { font-family:monospace; font-weight:normal; font-style:normal; }
</style>
</head>
<body>
<img style="position:absolute; left:0px; top:0px;" width="595" height="842" src="page3.png"">
<div class="txt" style="position:absolute; left:253px; top:89px;"><span class="f1" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">Ministry of Health - MS</span></div>
<div class="txt" style="position:absolute; left:196px; top:103px;"><span class="f1" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">National Health Surveillance Agency </span><span class="f2" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">â€“ </span><span class="f1" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">ANVISA</span></div>
<div class="txt" style="position:absolute; left:277px; top:131px;"><span class="f1" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">Section</span></div>
<div class="txt" style="position:absolute; left:271px; top:154px;"><span class="f1" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">III</span></div>
<div class="txt" style="position:absolute; left:271px; top:176px;"><span class="f1" style="font-size:11px;vertical-align:baseline;color:rgba(0,0,0,1);">Definitions</span></div>
<div class="txt" style="position:absolute; left:145px; top:196px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">Article 4 For the purposes of this Resolution the following shall apply</span></div>
<div class="txt" style="position:absolute; left:84px; top:211px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">definitions, which can have different meaning in another context.</span></div>
<div class="txt" style="position:absolute; left:144px; top:233px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">I - accessory (of a medical device): a product intended by its manufacturer</span></div>
<div class="txt" style="position:absolute; left:84px; top:248px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">to be used in conjunction with one or more specific medical devices, to permit or assist</span></div>
<div class="txt" style="position:absolute; left:84px; top:262px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">specifically and directly that the medical device(s) are used for the intended purpose;</span></div>
<div class="txt" style="position:absolute; left:144px; top:284px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">II - agglomerate: for the purpose of defining nanomaterial, a set of weakly</span></div>
<div class="txt" style="position:absolute; left:84px; top:299px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">bound particles in which the resulting external surface area is equal to the sum of the</span></div>
<div class="txt" style="position:absolute; left:84px; top:313px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">surface areas of the individual components;</span></div>
<div class="txt" style="position:absolute; left:144px; top:336px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">III - aggregate: for the purpose of the definition of nanomaterial, a particle</span></div>
<div class="txt" style="position:absolute; left:84px; top:351px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">comprising heavily bonded or fused particles, in which the resulting external surface</span></div>
<div class="txt" style="position:absolute; left:84px; top:366px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">area may be significantly less than the sum of the calculated surface areas of the</span></div>
<div class="txt" style="position:absolute; left:84px; top:380px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">individual components;</span></div>
<div class="txt" style="position:absolute; left:144px; top:402px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">IV - Change: Modification of information submitted to Anvisa in the</span></div>
<div class="txt" style="position:absolute; left:84px; top:417px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">notification process or registration of the medical device and in its respective</span></div>
<div class="txt" style="position:absolute; left:84px; top:431px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">secondary petitions;</span></div>
<div class="txt" style="position:absolute; left:144px; top:453px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">V - Change of approval required: Amendment of greater sanitary</span></div>
<div class="txt" style="position:absolute; left:84px; top:468px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">relevance, which deals with change to be introduced in the registration process, being</span></div>
<div class="txt" style="position:absolute; left:84px; top:482px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">authorized in national territory only after technical documentary analysis and</span></div>
<div class="txt" style="position:absolute; left:84px; top:497px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">favorable manifestation of Anvisa;</span></div>
<div class="txt" style="position:absolute; left:144px; top:519px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">VI - Change of immediate implementation: Change of medium health</span></div>
<div class="txt" style="position:absolute; left:84px; top:534px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">relevance, which deals with a change to be introduced in the notification or</span></div>
<div class="txt" style="position:absolute; left:84px; top:548px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">registration process, and its implementation is authorized in national territory after</span></div>
<div class="txt" style="position:absolute; left:84px; top:563px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">filing a petition with Anvisa;</span></div>
<div class="txt" style="position:absolute; left:144px; top:586px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">VII - Non-reportable change: Any other change of less sanitary relevance,</span></div>
<div class="txt" style="position:absolute; left:84px; top:600px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">resulting from a change that is not classified as required approval or immediate</span></div>
<div class="txt" style="position:absolute; left:84px; top:615px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">implementation, and that does not depend on protocol in Anvisa for implementation;</span></div>
<div class="txt" style="position:absolute; left:144px; top:637px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">VIII - Holder (notification or registration): Legal entity, public or private,</span></div>
<div class="txt" style="position:absolute; left:84px; top:652px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">manufacturer or importer, responsible for the medical device in national territory,</span></div>
<div class="txt" style="position:absolute; left:84px; top:666px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">which holds the concession of marketing of medical device, issued by Anvisa;</span></div>
<div class="txt" style="position:absolute; left:144px; top:688px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">IX - Surgically invasive device: Invasive device that penetrates the body</span></div>
<div class="txt" style="position:absolute; left:84px; top:703px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">through its surface, including through the mucous membranes of the body holes, in the</span></div>
<div class="txt" style="position:absolute; left:84px; top:718px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">context of a surgical intervention; and device that penetrates the body by a route other</span></div>
<div class="txt" style="position:absolute; left:84px; top:732px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">than a body hole;</span></div>
<div class="txt" style="position:absolute; left:145px; top:782px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);">This text does not replace the published in the Official Gazette.</span></div>
</body>
</html>
